GlassScriptPhysician profile
Jodi K Maranchie
NPI 1750362752
$5,422.89
in general payments reported to CMS, 2019-2025
11 companies · $750 in 2025
The $750 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $2,656 · 2021: $1,500 · 2022: $100 · 2023: $98.60 · 2024: $146 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,656.00 | 2020 | |
| Merck Sharp & Dohme LLC | $1,500.00 | 2021 | |
| Exelixis INC. | $320.83 | 2024-2025 | Cabometyx |
| Boston Scientific Corporation | $257.95 | 2023-2025 | Moses, Lithovue |
| Calyxo, INC. | $200.46 | 2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $157.93 | 2019 | |
| Ferring Pharmaceuticals INC. | $140.04 | 2025 | Adstiladrin |
| Janssen Research & Development, LLC | $100.00 | 2022 | |
| Janssen Biotech, INC. | $75.05 | 2025 | Erleada |
| Pfizer INC. | $14.63 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Maranchie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.